Melanóma: vizsgálatok itt: Csehország
8 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 4. fázisTaking peopleDabrafenib and/or Trametinib Rollover Study
- Where
- Brno, Prague
- Életkor
- 18 év to 100 év
- People
- 100 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT03340506 · EU 2023-509318-13-00 - No phaseTaking peopleEarly Detection of Skin Tumors Using a Telemedicine Tool in Primary Care
- Where
- Brno, Olomouc, Pilsen, Prague
- Életkor
- 50 év and over
- People
- 1440
- Run by
- Institute of Health Information and Statistics of the Czech Republic
See details and how to joinNCT07349940 - No phaseTaking peopleDetection of the BRAF V600E Mutation in Liquid Biopsy Using the CRISPR/Cas12a System
- Where
- Brno
- Életkor
- 18 év and over
- People
- 17
- Run by
- Masaryk Memorial Cancer Institute
See details and how to joinNCT07870265 - 2/3. fázisTaking peopleSafety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
- Where
- Brno-Stred, Novy Hradec Kralove, Olomouc
- Életkor
- 18 év and over
- People
- 740 worldwide
- Run by
- Eikon Therapeutics
See details and how to joinNCT06697301 · EU 2024-512659-19-00 - 3. fázisTaking peopleStudy to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
- Where
- Hradec Králové
- Életkor
- 18 év to 70 év
- People
- 670 worldwide
- Run by
- Iovance Biotherapeutics, Inc.
See details and how to joinNCT05727904 · EU 2022-503140-41-00 - 3. fázisCsak meghívásosA Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal Melanoma
- Where
- Plzen 23, Prague, Prague 6
- Életkor
- 18 év and over
- People
- 100 worldwide
- Run by
- Aura Biosciences
See details and how to joinNCT07338968 · EU 2025-524405-33-00 - 3. fázisTaking peopleNeoadjuvant Darovasertib in Primary Uveal Melanoma
- Where
- Prague 6
- Életkor
- 18 év and over
- People
- 520 worldwide
- Run by
- IDEAYA Biosciences
See details and how to joinNCT07015190 · EU 2025-522387-32-00 - 3. fázisTaking peopleIMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
- Where
- Hradec Králové, Olomouc, Prague
- Életkor
- 18 év and over
- People
- 680 worldwide
- Run by
- Immunocore Ltd
See details and how to joinNCT06112314